6 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Heparin, Fondaparinux ... accelerates the bridging ... #UFH #DOAC #Dabigatran ... #Apixaban #Rivaroxaban ... NOAC #Mechanism
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... Xa inhibitors - Apixaban ... #pharmacology #medications ... #doac #comparison ... #table #management
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... filtration rate; DOAC ... molecular weight heparin ... #DOAC #VTE #Malignancy ... #Management #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
DOAC, direct oral ... low-molecular-weight heparin ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
♀, ↑Age, ESRD Pathophysiology ... : Argatroban, Fondaparinux ... , Bivalirudin, DOAC ... #Management #Treatment ... #Hematology #HemeOnc
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
: • Initial heparin ... typically needed • DOACs ... (rivaroxaban, apixaban ... Fibrillation #AFib #diagnosis ... #management #cardiology